Fintel reports that on February 14, 2025, UBS initiated coverage of Alvotech (NasdaqGM:ALVO) with a Buy recommendation.
Hosted on MSN29m
UBS Downgrades enGene Holdings (ENGN)Fintel reports that on February 14, 2025, UBS downgraded their outlook for enGene Holdings (NasdaqCM:ENGN) from Buy to Neutral. Analyst Price Forecast Suggests 382.56% Upside As of January 28, 2025, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback